These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27363581)

  • 1. Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity.
    Nguyen DP; Miyaoka Y; Gilbert LA; Mayerl SJ; Lee BH; Weissman JS; Conklin BR; Wells JA
    Nat Commun; 2016 Jul; 7():12009. PubMed ID: 27363581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond Native Cas9: Manipulating Genomic Information and Function.
    Mitsunobu H; Teramoto J; Nishida K; Kondo A
    Trends Biotechnol; 2017 Oct; 35(10):983-996. PubMed ID: 28739220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing.
    Lu J; Zhao C; Zhao Y; Zhang J; Zhang Y; Chen L; Han Q; Ying Y; Peng S; Ai R; Wang Y
    Nucleic Acids Res; 2018 Mar; 46(5):e25. PubMed ID: 29237052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of CRISPR-Cas9 on target identification and validation.
    Moore JD
    Drug Discov Today; 2015 Apr; 20(4):450-7. PubMed ID: 25572406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing.
    Bolukbasi MF; Liu P; Luk K; Kwok SF; Gupta A; Amrani N; Sontheimer EJ; Zhu LJ; Wolfe SA
    Nat Commun; 2018 Nov; 9(1):4856. PubMed ID: 30451839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cas9 immunity creates challenges for CRISPR gene editing therapies.
    Crudele JM; Chamberlain JS
    Nat Commun; 2018 Aug; 9(1):3497. PubMed ID: 30158648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Split Staphylococcus aureus Cas9 as a Compact Genome-Editing Tool in Plants.
    Kaya H; Ishibashi K; Toki S
    Plant Cell Physiol; 2017 Apr; 58(4):643-649. PubMed ID: 28371831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL
    Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly efficient heritable plant genome engineering using Cas9 orthologues from Streptococcus thermophilus and Staphylococcus aureus.
    Steinert J; Schiml S; Fauser F; Puchta H
    Plant J; 2015 Dec; 84(6):1295-305. PubMed ID: 26576927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an Efficient Genome Editing Method by CRISPR/Cas9 in a Fish Cell Line.
    Dehler CE; Boudinot P; Martin SA; Collet B
    Mar Biotechnol (NY); 2016 Aug; 18(4):449-52. PubMed ID: 27236514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The application of CRISPR/Cas9 genome editing technology in cancer research].
    Wang DY; Ma N; Hui Y; Gao X
    Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
    Altenbuchner J
    Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells.
    Daer RM; Cutts JP; Brafman DA; Haynes KA
    ACS Synth Biol; 2017 Mar; 6(3):428-438. PubMed ID: 27783893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chemical-inducible CRISPR-Cas9 system for rapid control of genome editing.
    Liu KI; Ramli MN; Woo CW; Wang Y; Zhao T; Zhang X; Yim GR; Chong BY; Gowher A; Chua MZ; Jung J; Lee JH; Tan MH
    Nat Chem Biol; 2016 Nov; 12(11):980-987. PubMed ID: 27618190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of CRISPR-Cas9 genome interrogation in living cells.
    Knight SC; Xie L; Deng W; Guglielmi B; Witkowsky LB; Bosanac L; Zhang ET; El Beheiry M; Masson JB; Dahan M; Liu Z; Doudna JA; Tjian R
    Science; 2015 Nov; 350(6262):823-6. PubMed ID: 26564855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of a split-Cas9 enzyme complex.
    Wright AV; Sternberg SH; Taylor DW; Staahl BT; Bardales JA; Kornfeld JE; Doudna JA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(10):2984-9. PubMed ID: 25713377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.